QuickRad
Aikenist Technologies Pvt Ltd • Radiology • 02/21/2025
Device Purpose
The QuickRad system is a web-based, Class II medical device designed for comprehensive management and processing of DICOM-compliant medical images, enabling distributed access and optional integration with third-party AI models. Its scientific basis lies in secure, validated software architecture and robust data handling protocols, confirmed through non-clinical testing to ensure safety and effectiveness for proficient medical practitioners.
Summary
Aikenist Technologies Pvt Ltd has received clearance for its QuickRad system, a web-based solution for managing and processing medical images. This Class II medical image management and processing system has been determined to be substantially equivalent to other legally marketed systems for its specified indications for use, allowing it to be marketed. QuickRad is designed to receive, store, transmit, process, and display medical images and associated data from various DICOM-compliant sources, such as CT, MRI, ultrasound, and X-ray devices. It enhances communication and accessibility by allowing distributed access to images and data across computer networks, and offers optional integration with cleared third-party AI models. The system is intended for use by proficient and certified medical practitioners, including physicians, radiologists, and medical technicians. Non-clinical testing, including risk management, cybersecurity, usability, and software validation, confirmed its safety and effectiveness.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific types of medical images (e.g., diagnostic vs. interventional) are primarily managed and processed by QuickRad, and are there any limitations to image complexity or resolution?; How does the "optional integration with cleared third-party AI models" function, and what are the clinical validation requirements for these integrated AI capabilities?; What are the specific cybersecurity protocols and data encryption standards implemented by QuickRad to ensure patient data privacy and prevent unauthorized access during distributed transmission?; Can QuickRad facilitate real-time image consultation or collaborative diagnostics among distributed medical practitioners, and what are the latency implications for large image files?; What post-market surveillance plans are in place to monitor the long-term safety, effectiveness, and evolving cybersecurity threats for the QuickRad system?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, CBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Not detected in AI-generated device summary: SBOM, ML-BOM, HBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly